Psychedelic therapy in the treatment of addiction: the past, present and future
Frontiers in Psychiatry · 12.06.2023 · 14
DOI: 10.3389/fpsyt.2023.1183740 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 12.06.2023. Verfasst von Rayyan Zafar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Psychedelic therapy has witnessed a resurgence in interest in the last decade from the scientific and medical communities with evidence now building for its safety and efficacy in treating a range of psychiatric disorders including addiction. In this review we will chart the research investigating the role of these interventions in individuals with addiction beginning with an overview of the current socioeconomic impact of addiction, treatment options, and outcomes. We will start by examining historical studies from the first psychedelic research era of the mid-late 1900s, followed by an overview of the available real-world evidence gathered from naturalistic, observational, and survey-based studies. We will then cover modern-day clinical trials of psychedelic therapies in addiction from first-in-human to phase II clinical trials. Finally, we will provide an overview of the different translational human neuropsychopharmacology techniques, including functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), that can be applied to foster a mechanistic understanding of therapeutic mechanisms. A more granular understanding of the treatment effects of psychedelics will facilitate the optimisation of the psychedelic therapy drug development landscape, and ultimately improve patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
- Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
- Clinical Psychopharmacology Unit, University College London, London, United Kingdom.
- Invicro, London, United Kingdom.
Zitieren
APA
Zafar, R., Siegel, M., Harding, R., Barba, T., Agnorelli, C., Suseelan, S., Roseman, L., Wall, M., Nutt, D. J., & Erritzoe, D. (2023). Psychedelic therapy in the treatment of addiction: the past, present and future. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1183740
Vancouver
Zafar R, Siegel M, Harding R, Barba T, Agnorelli C, Suseelan S, et al. Psychedelic therapy in the treatment of addiction: the past, present and future. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1183740
BibTeX
@article{Zafar2023,
author = {Zafar, Rayyan and Siegel, Maxim and Harding, Rebecca and Barba, Tommaso and Agnorelli, Claudio and Suseelan, Shayam and Roseman, Leor and Wall, Matthew and Nutt, David John and Erritzoe, David},
title = {Psychedelic therapy in the treatment of addiction: the past, present and future},
journal = {Frontiers in Psychiatry},
year = {2023},
volume = {14},
doi = {10.3389/fpsyt.2023.1183740}
}
EUVIMED